by in
Entry Author Date Location
Indel Grabs $1.4M for Antibiotics 04/28/11 Seattle
Xenoport Wins FDA Green Light, The Coming ‘HealthTech’ Wave, More Genomes Go Public, & More Bay Area Life Sciences News 04/08/11 San Francisco
Optimer Antibiotic Gets Panel Nod, CareFusion Buys Vestara, Tracon Raises $16.5M, & More San Diego Life Sciences News 04/07/11 San Diego
Omeros Flunks Pivotal Trials, Dendreon’s Shareholder Hubbub, AVI Biopharma Nabs $30M, & More Seattle-Area Life Sciences News 04/07/11 Seattle
Optimer Inks Potential $47.5M-Plus Deal with Cubist to Help Sell Antibiotic 04/06/11 San Diego
Optimer Wins FDA Panel Nod, Still Wrestling With Language to Describe Benefit 04/05/11 San Diego
Cubist Settles Key Litigation 04/05/11 Boston
Biotechies Need to Get Serious About Antibiotics, Where There is Money to Be Made 04/04/11 National
Optimer Nabs $68M in Stock Sale 02/11/11 San Diego
Optimer Pockets $68M Upfront From Astellas For Rights to Antibiotic in Europe 02/07/11 San Diego
Rib-X Raises Another $20M, Led by Warburg Pincus, to Develop Late Stage Antibiotics 01/11/11 Boston
E-Commerce Pioneer Sets Up Cancer Commons, Affymax Hires New Boss, Plexxikon Opts In, & More Bay Area Life Sciences News 01/07/11 San Francisco
Genentech Licenses AMRI Compounds 01/04/11 Seattle
Avalon Funds Antibiotics Development at New Startup, RQx Pharmaceuticals 12/14/10 San Diego
Optimer Seeks Quick Green Light From FDA for Antibiotic Against Deadly Bug 11/30/10 San Diego
Glaxo Buys $129M in Theravance Stock 11/29/10 San Francisco
Optimer Halts Study After Antibiotic for Traveler’s Diarrhea Linked to Rash; Shares Drop 11/10/10 San Diego
Cytomx Pockets $30M, AvidBiotics Eyes Food Safety Market, Rigel Passes Arthritis Trial, & More Bay Area Life Sciences News 09/24/10 San Francisco
AvidBiotics Creates Novel Proteins that Kill Bacteria on the Farm, in the Lab, in the Body 09/21/10 San Francisco
Tetraphase Shows What the $45M Was All About at Big Antibiotics Conference 09/15/10 Boston
Why We Think Investing in Antibiotics Makes Sense 09/14/10 San Francisco
Trius Ends First Day Trading at $5 a Share 08/03/10 San Diego
Trius Chops IPO Price, Offers More Shares 08/02/10 San Diego
Optimer Seeks EU Approval 07/29/10 San Diego
Achaogen, Flush with $56M, Seeks to Build Lasting Company with Potent Antibiotics 07/19/10 San Francisco
Trius IPO Plans Back on Track 07/15/10 San Diego
$4.5M for Excelimmune 07/07/10 Boston
Trius Gets FDA Clarity 06/16/10 San Diego
Follica Grabs $7.5M, Glaxo’s SR One Leads $22M Round For Constellation, MoMelan Seeks to Improve Skin Grafts, & More Boston-Area Life Sciences News 06/04/10 Boston
Tetraphase Nails $45M Round to Test Pipeline of New Antibiotics 06/01/10 Boston
Page 3 of 5 « previous page · next page »